SCHEMBL14029463

SCHEMBL14029463

Cc1ccccc1-n1c2ccccc2c2cc(-c3ccc(Nc4ccccc4)cc3)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TSPO P30536 1/20 0.38
HPGD P15428 1/20 0.37
LMNA P02545 4/20 0.36
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
RAB9A P51151 1/20 0.36
TSHR P16473 2/20 0.35
L3MBTL1 Q9Y468 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21037653 0.89 TSPO (0.45) TSPOLMNAALDH1A1SMN1; SMN2RAB9A
SCHEMBL14029485 0.85 ALDH1A1 (0.37) TSPOLMNAALDH1A1MEN1KMT2A
SCHEMBL21037665 0.84 NOTUM (0.41) TSPOLMNAALDH1A1TSHRL3MBTL1
SCHEMBL14029540 0.84 TSPO (0.38) TSPOLMNAALDH1A1MEN1MAPT
SCHEMBL14029516 0.84 SERPINE1 (0.37) TSPOHPGDLMNAALDH1A1TSHR
SCHEMBL21037662 0.82 ALDH1A1 (0.39) TSPOLMNAALDH1A1TSHRL3MBTL1
SCHEMBL15435756 0.82 L3MBTL1 (0.46) TSPOLMNAALDH1A1SMN1; SMN2RAB9A
SCHEMBL14029508 0.82 L3MBTL1 (0.55) TSPOHPGDLMNAALDH1A1MEN1
SCHEMBL29839708 0.82 L3MBTL1 (0.55) TSPOHPGDLMNAALDH1A1MEN1
SCHEMBL609950 0.82 L3MBTL1 (0.55) TSPOHPGDLMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11171292-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-11-09 US disclosed
US-20200373488-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2020-11-26 US disclosed
US-20180083191-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2018-03-22 US disclosed
US-9831440-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-11-28 US disclosed
US-20170018711-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2017-01-19 US disclosed
US-9461248-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-10-04 US disclosed
US-20150005509-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED SEMICONDUCTOR ENERGY LAB (JP) 2015-01-01 US disclosed
US-8835018-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-16 US disclosed
US-8835018-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-16 US disclosed
EP-1985613-B1 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LAB (JP) 2013-05-15 EP disclosed
US-20080268284-A1 Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-10-30 US disclosed
US-20080268284-A1 Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-10-30 US disclosed
EP-1985613-A2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080268284-A1 Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption CRY1, CRY2, CYBA JUN 2588/4885NFKB1 748/4885NFKB2 1467/4885
US-20170018711-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED CYP1A1, CYP1A2, XPOT JUN 750/4885NFKB1 2180/4885NFKB2 1410/4885
US-20200373488-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED CYP1A1, CYP1A2, XPOT JUN 750/4885NFKB1 2180/4885NFKB2 1410/4885
US-11171292-B2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used CYP1A1, CYP1A2, XPOT JUN 750/4885NFKB1 2180/4885NFKB2 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.